跳至主要内容

Medicilon ion channel screening service

 Medicilon has a team of more than 100 chemists, and has experience in research and development cooperation with large pharmaceutical companies and biotechnology companies well-known at home and abroad. Under the leadership of experienced medicinal chemistry leaders, Medicilon provides customers with new drug development services covering a variety of targets and diseases, including from active compound discovery, target verification, lead compound optimization to the selection of preclinical drug candidates. Details.

Services: Primary and secondary screening of various ion channel drugs, discovery and optimization of lead compounds, safety evaluation, and positioning of drug targets, etc.

Detection method: automatic patch clamp or real-time fluorescence dynamic detection system

Ion channels are one of the cornerstones of living organisms to maintain normal functions. The bioelectric signals mediated by them play a key role in all life processes such as heart beating, hormone secretion, signal transduction and cognitive memory. The mutation of ion channels at the genetic level can lead to a variety of diseases including nervous system, cardiovascular system and endocrine system diseases, so it is one of the most important drug targets and one of the indicators of drug safety evaluation. The functional detection of ion channels relies on the measurement of tiny currents mediated by them. Due to the limitation of technical means, the low screening flux of compounds has become the bottleneck and key step of drug discovery for ion channels.

The commonly used screening models are at the molecular level and the cellular level. The interaction between the drug and the molecular target is observed, and the basic mechanism of action of the drug can be directly understood.
Molecular-level drug screening model: receptor screening model; enzyme screening model; ion channel screening model
Ion channel screening model:
(1) High-throughput screening of shellfish toxins, the target of which is the saxitoxin binding site on the Na+ channel, and a competitive binding test with radioligands was conducted to examine the tested samples.
(2) High-throughput screening of small molecules that interfere with the interaction between the β3 subunit of the N-type calcium channel and the α1β subunit using yeast two-hybrid methods to find new calcium channel antagonists.
Main functions and research methods of ion channels
The main functions of the ion channel are:
(1) Increase the intracellular calcium concentration, thereby triggering a series of physiological effects such as muscle contraction, cell excitement, gland secretion, Ca2+-dependent ion channel opening and closing, protein kinase activation and gene expression regulation;
(2) In excitatory cells such as nerves and muscles, Na+ and Ca2+ channels mainly regulate depolarization, and K+ mainly regulates repolarization and maintains resting potential, thereby determining the excitability, refractoryness and conductivity of cells;
(3) Regulate vasomotor smooth muscle contraction and contraction activities, including K+, Ca2+, Cl- channels and some non-selective cation channels;
(4) Participate in synaptic transmission, including K+, Na+, Ca2+, Cl- channels and some non-selective cation channels;
(5) Maintain the normal volume of cells. In the hypertonic environment, the activation of ion channels and transport systems causes Na+, Cl-, organic solutions and water to enter the cells to regulate the increase in cell volume; in the hypotonic environment, Na+, Cl- , Organic solution and water flow out of the cell to regulate cell volume reduction.
The most direct way to study the function of ion channels is to use patch clamp technology to directly measure the current through the ion channel or to measure changes in cell membrane potential. Patch clamp technology is to use a glass micropipette electrode to complete the monitoring or clamping of the membrane or whole cell potential. And the recording of membrane currents, analyze the molecular activities of individual or groups of channels, and discuss the characteristics of ion channels by observing the changes of membrane currents. Molecular biology technology provides powerful tools for molecular structure analysis, gene cloning, and functional expression studies of ion channels. For the gene structure encoding the ion channel subunit, gene location cloning can be used to determine its location on the chromosome, reverse transcription-polymerase chain reaction, Northern hybridization, etc. to clarify its distribution in organ tissues, and Western hybridization to detect gene expression products Fluorescent probe calcium image analysis technology provides an effective means for detecting intracellular free calcium ion concentration. Commonly used fluorescent probes are Fura-2/AM, Indo-1/AM, Fluo-3/AM, Calcium Green, etc. Commonly used detection instruments include dual-wavelength microfluorescence photometer, laser scanning confocal microscope, etc. At present, foreign companies such as Olympus, Zeiss, Spex, etc. have produced micro-fluorescence devices for measuring intracellular free calcium ions, and domestically developed living cells Calcium ion fluorescence microscopic detection system has also been introduced. Combining ion concentration image recording and patch-clamp recording, simultaneous photoelectric detection is used to study ion channels from the aspects of ion concentration, image changes, and electrical signal changes generated by ions, and more information about ion channel functions will be obtained.

Contact Us:

Email : marketing@medicilon.com

Tel : +44 1223 981 792 (Europe)

+82 (0)70-8269-5849 (South Korea)

08044216898 (Japan)

+86 021 58591500 (China)

Website: https://www.medicilon.com

Related Articles:

Ion Channel Screening Services

评论

此博客中的热门博文

What is preclinical testing?

In the process of  preclinical testing  of a compound or biological agent into a drug, the compound involved must go through the testing phase. First, we need to identify potential targets that can treat the disease. Then, a variety of compounds or preparations are screened out. Any compound that has shown potential as a drug for the treatment of this disease needs to be tested for toxicity before clinical testing to reduce the possibility of injury. preclinical testing What is the basis of preclinical testing? According to US Food and Drug Administration (FDA) regulations, a series of tests are required before a new drug is approved for use. In the first stage, basic research determines a hypothetical target for the treatment of a certain disease, and then screens small molecules or biological compounds to discover any substance with the potential to treat the disease. Then, a  preclinical research  phase followed, before which, as described above, the potential toxicity of the compou

Inventory of the three major in vitro pharmacokinetic research methods

  The metabolic properties of a compound are an essential factor in whether or not it can be used as a drug in the clinical setting, so pharmacokinetic studies of newly synthesized compounds are required in drug development. In vitro incubation with liver microsomes, recombinant CYP450 enzyme lines, and in vitro incubation with hepatocytes are some of the more common in vitro drug metabolism methods. 1. In vitro incubation method with liver microsomes The metabolic stability and metabolic phenotypes of candidate compounds in different species of liver microsomes are good predictors of the metabolic properties of compounds in vivo. They are practical tools for evaluating candidate compounds in the pre-development phase of drug development. Liver microsomes include rat liver microsomes, human liver microsomes, canine liver microsomes, monkey liver microsomes, and mouse liver microsomes. In in vitro incubation of the liver, microsomes are the "gold standard" for in vitro d

Novel Parkinson’s Therapies Possible with New Mouse Model

Parkinson's disease (PD) is a neurodegenerative disorder that is marked by the accumulation of the protein, α-synuclein (αS), into clumps known as Lewy bodies, which diminish neural health. Now, researchers from Brigham and Women's Hospital (BWH) report the development of a mouse model to induce PD-like αS aggregation, leading to resting tremor and abnormal movement control. The mouse responds to L-DOPA, similarly to patients with PD. The team's study (“Abrogating Native α-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson’s Disease”) on the use of this transgenic mouse model appears in  Neuron . “α-Synuclein (αS) regulates vesicle exocytosis but forms insoluble deposits in PD. Developing disease-modifying therapies requires animal models that reproduce cardinal features of PD. We recently described a previously unrecognized physiological form of αS, α-helical tetramers, and showed that familial PD-causing missense mutati